The original instrument and the following digest, which constitutes no part of the
legislative instrument, were prepared by Beth O'Quin.
DIGEST
SB 118 Original 2022 Regular Session Talbot
Present law provides coverage can be subject to annual deductibles, coinsurance, copayment
provisions established under a health coverage plan and coverage for genetic testing of certain cancer
mutations can be subject to applicable evidence-based medical necessity criteria under a health plan.
Proposed law removes provision that genetic testing of certain cancer mutations can be subject to
evidence-based medical necessity criteria under a health plan but requires medical necessity for
genetic testing of certain cancer mutations based on nationally recognized clinical practice guidelines
from institutions like the National Comprehensive Cancer Network, the American Cancer Society,
and the Food and Drug Administration labeling.
Effective on July 1, 2022.
(Amends R.S. 22:1028.3(B)(2))